期刊文献+

Kobayashi评分体系在中国川崎病患儿中的临床应用价值 被引量:9

Clinical Values of Kobayashi Scoring System in Chinese Children with Kawasaki Disease
暂未订购
导出
摘要 目的探讨在川崎病(Kawasaki disease,KD)初始治疗前,Kobayashi评分体系预测中国KD患儿并发冠状动脉损伤(CAL)的能效。方法回顾性分析113例KD患儿临床资料,将其分为冠状动脉损伤组(CAL组)与非冠状动脉损伤组(NCAL组);应用Kobayashi评分体系对所有患儿评分,用χ2检验分析各评分参数及依危险程度分组后的CAL发生率有无统计学差异,并分析该评分体系的能效。结果 CAL组43例,NCAL组70例,根据该评分体系分为低危组80例、高危组33例,单因素分析结果显示谷草转氨酶(AST)≥100U/L、外周血中性粒细胞百分比≥80%、C反应蛋白(CRP)≥100mg/L、年龄≤1岁是KD患儿并发CAL的危险因素,Kobayashi评分高危组的CAL发生率明显高于低危组(均P<0.05);该评分体系的灵敏度为0.56、特异度为0.87、符合率Kappa值为0.50。结论 Kobayashi评分体系的7个参数中AST≥100U/L、外周血中性粒细胞%≥80%、CRP≥100mg/L、年龄≤1岁被证明是中国KD患儿并发CAL的危险因素;该评分体系虽然可以预测中国KD患儿是否并发CAL,但能效不高。 Objective To investigate the energy efficiency of Kobayashi scoring system to identify the Chinese children complicated with coronary artery lesions(CAL)from Kawasaki disease(KD)children before initial treatment.Methods The clinical data of 113 cases of KD were retrospectively analyzed,and divided into CAL group and non-CAL group.Kobayashi scoring system was applied to score for all patients,and the χ2 tests were used to compare CAL incidence between the scoring parameters respectively and the two risk groups.The energy efficiency of Kobayashi scoring system was analyzed.Results There were 43 cases in CAL group,and 70 cases in non-CAL group,and according to the scoring system,80 cases were divided into low-risk group,and 33 cases into high-risk group.Single factor analysis showed that AST ≥ 100 U/L,neutrophil ≥ 80%,CRP ≥ 100 mg/L,aged ≤ 1-year-old were the risk factors of CAL in KD children.The CAL incidence in high-risk group was significantly higher than in low-risk group(all P0.05).The sensitivity,specificity and Kappa value of the Kobayashi scoring system was 0.56,0.87,and 0.50 respectively.Conclusion Among the seven parameters of Kobayashi scoring system,AST ≥ 100 U/L,neutrophil ≥ 80%,CRP ≥ 100 mg/L,and aged ≤ 1-year-old were proved to be the risk factors of CAL in Chinese KD patients.The scoring system had ability to predict the CAL in KD patients,but the energy efficiency was not high enough.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2011年第6期746-749,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
关键词 川崎病 冠状动脉损伤 评分体系 Kawasaki disease coronary artery lesions scoring system
  • 相关文献

参考文献18

  • 1Rowley A H,Shulman S T.Pathogenesis and management of Kawasaki disease[J].Expert Rev Anti Infect Ther,2010,8(2):197-203.
  • 2Burns J C,Glode M P.Kawasaki syndrome[J].Lancet,2004,364(9433):533-544.
  • 3Newburger J W,Fulton D R.Kawasaki disease[J].Curr Opin Pediatr,2004,16(5):508-514.
  • 4Iemura M,Ishii M,Sugirnura T,et al.Long term conseque-nces of regressed coronary aneurysms after Kawasaki disease:vascular wall morphology and function[J].Heart,2000,83(3):307-311.
  • 5Fukazawa R,Ogawa S.Long-term prognosis of patients with Kawasaki disease:at risk for future atherosclerosis?[J].J Nippon Med Sch,2009,76(3):124-133.
  • 6Kobayashi T,Inoue Y,Takeuchi K,et al.Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J].Circulation,2006,113(22):2606-2612.
  • 7Ayusawa M,Sonobe T,Uemura S,et al.Kawasaki disease r-esearch committee.Revision of diagnostic guidelines for Kawasaki disease(the 5th revised edition)[J].Pediatr Int,2005,47(2):232-234.
  • 8Research Committee on Kawasaki Disease.Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease[R].Tokyo:Japan Ministry of Health and Welfare,1984.
  • 9Eue I,Konig S,Pior J,et al.S100A8,S100A9 and the S100-A8/A9 heterodimer complex specifically bind to human endothelial cells:identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8 /A9 on human dermal microvascular endothelial cell line-1 cells[J].Int Immunol,2002,14(3):287-297.
  • 10Takahashi K,Oharaseki T,Naoe S.Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease[J].Pediatr Int,2005,47(3):305-310.

二级参考文献16

  • 1Takahashi K,Oharaseki T,Naoe S,et al.Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease[J].Pediatr Int.,2005,47 (3):305-310.
  • 2Singh-Grewal D,Wong M,Isaacs D.Diagnosis,treatment and outcome of Kawasaki disease in an Australian tertiary setting:a review of three years experience[J].J Paediatr Child Health,2005,41 (10):495-499.
  • 3Kawasaki T.Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children (Japanese)[J].Japan J Allergy,1967,16:178-122.
  • 4Du ZD,Zhang T,Liang L,et al.Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999[J].Pediatr Infect Dis J,2002,21 (2):103-107.
  • 5Falcini F,Cimaz R,Calabri GB,et al.Kawasaki disease in northem Italy:a multicenter retrospective study of 250 patients.Clin Exp Rheumatol[J].2002 May-Jun,20(3):421-426.
  • 6Zhang T,Yanagawa H,Oki I,et al.Factors related to cardiac sequelae of Kawasaki disease[J].Eur J Pediatr,1999,158:694-697.
  • 7Salice P,Pietrogrande MC,Barbier P,et al.Cardiovascular abnormalities in Kawasaki disease:an Italian prospective study (Italian)[J].Cardiologia,1998,43 (12):1367-1374.
  • 8Laupland KB,Dele DH (1999).Epidemiology,etiology,and management of Kawasaki disease:state of the art[J].Pediatr Cardiol,20:177-183.
  • 9Koyanagi H,Nakamura Y,Yanagawa H.Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease[J].Acta Paediatr,1998,87:32-36.
  • 10Mori M,Imagawa T,Yasui K,et al.Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease[J].J Pediatr,2000,137(2):177-180.

共引文献60

同被引文献75

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部